E3 ubiquitin-protein ligase CHFR; checkpoint with forkhead & RING finger domains protein; RING finger protein 196 (CHFR, RNF196)
Jump to navigation
Jump to search
Function
- E3 ubiquitin-protein ligase
- functions in the antephase checkpoint by actively delaying passage into mitosis in response to microtubule poisons
- acts in early prophase before chromosome condensation, when the centrosomes move apart along the periphery of the nucleus
- probably involved in signaling the presence of mitotic stress caused by microtubule poisons by mediating Lys-48- linked ubiquitination of target proteins, leading to their degradation by the proteasome
- promotes ubiquitination & subsequent degradation of AURKA & PLK1
- probably acts as a tumor suppressor, possibly by mediating polyubiquitination of HDAC1, leading to its degradation
- may also promote formation of Lys-63-linked polyubiquitin chains & functions with the specific ubiquitin-conjugating UBC13-MMS2 (UBE2N-UBE2V2) heterodimer
- substrates polyubiquitinated at Lys-63 are usually not targeted for degradation, but are rather involved in signaling cellular stress
- protein modification; protein ubiquitination
- poly-ADP-ribosylated
- in addition to binding non covalently poly(ADP-ribose) via its PBZ-type Zn+2 finger, the protein is also covalently poly-ADP-ribosylated by PARP1
- autoubiquitinated; may regulate its cellular level
- phosphorylated upon DNA damage, probably by ATM or ATR
- phosphorylated by PKB
- phosphorylation may affect its E3 ligase activity
- interacts with HDAC1 & HDAC2
- interacts with PML (with sumoylated form of PML)
Structure
- the PBZ-type Zn+2 finger (CYR) mediates non- covalent poly(ADP-ribose)-bindin. g
- poly(ADP-ribose)-binding is dependent on the presence of Zn+2 & is required for its function in antephase checkpoint
- the FHA domain plays a key role in the anti-proliferative properties of the protein & is involved in initiating a cell cycle arrest at G2/M
- FHA domain may be required to interact with phosphorylated proteins
- belongs to the CHFR family
- contains 1 FHA domain
- contains 1 PBZ-type Zn+2 finger
- contains 1 RING-type Zn+2 finger
Compartment
Alternative splicing
named isoforms=5
Expression
- ubiquitous
- weakly expressed in G1 phase
- highly expressed during S phase
Pathology
- CHFR is silenced in many primary cancers because of CpG methylation & deacetylated histones on its promoter region; this raises the question of whether CHFR silencing is a consequence or a cause of primary cancers
More general terms
References
- ↑ UniProt http://www.uniprot.org/uniprot/Q96EP1.html
- ↑ Atlas of Genetics & Cytogenetics in Oncology & Haematology http://atlasgeneticsoncology.org/genes/CHFRID526.html